The autonomic nervous system (ANS) is a critical division of the peripheral nervous system that governs involuntary physiological processes, including heart rate, digestion, and respiratory rate. It is subdivided into two principal branches: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS). These two systems often exert opposing effects to maintain homeostasis. A classic example of this dual antagonistic control is the regulation of pupil diameter. The SNS, associated with “fight-or-flight” responses, causes pupillary dilation (mydriasis) to maximize light entry. Conversely, the PNS, which mediates “rest-and-digest” functions, causes pupillary constriction (miosis).
This control is mediated by two sets of muscles within the iris: the radially arranged dilator pupillae muscle, innervated by sympathetic nerves, and the circularly arranged sphincter pupillae muscle, innervated by parasympathetic nerves. The neurotransmitter for the parasympathetic system is acetylcholine (ACh), which acts on muscarinic receptors.
Pilocarpine is a parasympathomimetic alkaloid, meaning it mimics the effects of the parasympathetic nervous system. It is a direct-acting cholinergic agonist that preferentially stimulates muscarinic receptors. By acting as an analogue to acetylcholine, pilocarpine can be used to pharmacologically induce a parasympathetic response.
The following experiment is designed to observe and quantify the miotic effect of pilocarpine when applied topically to the eye of a frog (Rana tigrina or similar species). The frog serves as an excellent model organism due to its well-defined physiological responses and the relative simplicity of its handling in a laboratory setting. The primary objective is to demonstrate that pilocarpine induces pupillary constriction by directly stimulating the sphincter pupillae muscle, providing a tangible example of parasympathetic pharmacology.
Principle of the Experiment
The mechanism of action for this experiment is centered on the interaction between pilocarpine and the muscarinic receptors of the iris. When pilocarpine solution is instilled into the eye, it diffuses across the cornea and reaches the sphincter pupillae muscle. This muscle is rich in M3 muscarinic receptors. Pilocarpine binds to and activates these receptors, initiating the same intracellular signaling cascade that acetylcholine would.
The activation of M3 receptors, which are Gq protein-coupled, leads to the stimulation of phospholipase C. This enzyme cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers the release of calcium ions (Ca²⁺) from intracellular stores (the sarcoplasmic reticulum). The resulting increase in cytosolic Ca²⁺ concentration causes the smooth muscle fibers of the sphincter pupillae to contract. As this muscle is arranged in a circular fashion around the pupil, its contraction acts like a drawstring, causing the pupil to constrict and decrease in diameter. This observable physiological response is known as miosis. By using one eye as a control (receiving a saline solution) and the other as the test eye (receiving pilocarpine), the specific pharmacological effect of the drug can be isolated and confirmed.
Materials and Reagents
- Biological Specimen: One healthy, live frog (e.g., Rana tigrina).
- Chemicals/Reagents:
- Pilocarpine Hydrochloride solution (1% w/v in distilled water).
- Amphibian Ringer’s solution (as a control and for keeping the specimen moist). Composition: 6.5 g NaCl, 0.14 g KCl, 0.12 g CaCl₂, 0.2 g NaHCO₃ per 1 liter of distilled water.
- Anesthetic agent (e.g., tricaine methanesulfonate, MS-222) or equipment for pithing.
- Apparatus:
- Frog board or dissection tray.
- Cotton swabs or thread for securing the frog.
- Sterile droppers or micropipettes.
- Magnifying glass or dissecting microscope for clear observation.
- A fine-scale millimeter ruler or digital calipers for measuring pupil diameter.
- Stopwatch or timer.
- Beakers for solutions.
- Personal Protective Equipment (PPE): lab coat and gloves.
Procedure
- Animal Preparation and Immobilization: The humane treatment of the animal is paramount. The frog must be immobilized to ensure accurate measurements and prevent injury. This can be achieved through pithing, a technique that decerebrates the animal, rendering it insensitive to pain. A single pith is performed by inserting a pithing needle into the foramen magnum to destroy the brain. Alternatively, anesthesia can be used by immersing the frog in a dilute solution of MS-222 until it is unresponsive to tactile stimuli. Once immobilized, place the frog ventral side up on a frog board or in a dissection tray, securing its limbs gently with thread.
- Acclimatization and Baseline Measurement: Allow the immobilized frog to rest for 5-10 minutes under consistent, moderate lighting. This ensures that the pupils are in a stable state. Using a magnifying glass and a millimeter ruler or calipers, carefully measure the vertical diameter of the pupil in both eyes. Record these initial measurements as the baseline (Time = 0 minutes). Designate one eye as the “Control Eye” and the other as the “Test Eye.”
- Application of Control Solution: Using a clean dropper, instill 1-2 drops of Amphibian Ringer’s solution into the conjunctival sac of the designated Control Eye. This step is crucial to confirm that the physical act of applying liquid or the solution itself does not cause a change in pupil size.
- Application of Test Drug: Simultaneously, using a different clean dropper to prevent cross-contamination, instill 1-2 drops of the 1% Pilocarpine solution into the conjunctival sac of the Test Eye.
- Observation and Data Collection: Start the stopwatch immediately after the application of the solutions. Observe both eyes closely. At regular intervals of 5 minutes (i.e., at 5, 10, 15, 20, 25, and 30 minutes), measure and record the pupil diameter of both the Control Eye and the Test Eye. Record the data systematically in a table.
Sample Observation Table
| Time (minutes) | Pupil Diameter of Control Eye (mm) | Pupil Diameter of Test Eye (mm) |
|---|---|---|
| 0 (Baseline) | 4.0 | 4.0 |
| 5 | 4.0 | 3.5 |
| 10 | 4.0 | 2.8 |
| 15 | 3.9 | 2.1 |
| 20 | 4.0 | 1.5 |
| 25 | 4.0 | 1.4 |
| 30 | 4.0 | 1.4 |
- Post-Procedure Protocol: After the final measurement, gently irrigate both eyes with Ringer’s solution to wash out the remaining pilocarpine. Depending on institutional guidelines, the pithed animal should be disposed of according to biohazard protocols. If anesthetized, the animal should be monitored until recovery or humanely euthanized.
Expected Observations and Results
The results of the experiment should clearly demonstrate the pharmacological action of pilocarpine.
- Control Eye: The pupil diameter should remain relatively constant throughout the 30-minute observation period. Minor fluctuations may occur due to lighting changes or drying, but there will be no significant, progressive constriction.
- Test Eye: A noticeable and progressive decrease in pupil diameter (miosis) will be observed. The effect typically begins within the first 5-10 minutes and reaches its maximum level of constriction within 20-30 minutes, after which the pupil size will stabilize at its minimum diameter.
The data, when plotted on a graph with Pupil Diameter on the Y-axis and Time on the X-axis, will yield two distinct lines: a flat or near-flat line for the control eye and a downward-sloping curve for the test eye, which eventually plateaus.
Discussion and Conclusion
The observed miosis in the eye treated with pilocarpine confirms its role as a parasympathomimetic agent. By acting as a muscarinic receptor agonist, it directly stimulated the sphincter pupillae muscle, leading to its contraction and a reduction in pupillary aperture. The lack of response in the control eye effectively ruled out mechanical stimulation or the saline solution as causative factors, isolating the miotic effect to the pharmacology of pilocarpine.
This experiment serves as a powerful educational tool, illustrating the principles of autonomic pharmacology in a living system. It highlights the antagonistic control of the iris by the sympathetic and parasympathetic systems and demonstrates how exogenous drugs can be used to selectively manipulate these pathways. The clinical relevance of this mechanism is significant; pilocarpine is used in ophthalmology to treat conditions like glaucoma. By causing miosis and contracting the ciliary muscle, it enhances the outflow of aqueous humor, thereby reducing intraocular pressure.
In conclusion, the topical application of pilocarpine to the frog’s eye provides a definitive and reproducible demonstration of parasympathomimetic-induced miosis. The experiment successfully validates the drug’s mechanism of action and reinforces fundamental concepts of neuropharmacology.
References
- Katzung, B. G., Masters, S. B., & Trevor, A. J. (2018). Basic & Clinical Pharmacology (14th ed.). McGraw-Hill Education.
- Rang, H. P., Dale, M. M., Ritter, J. M., & Flower, R. J. (2016). Rang & Dale’s Pharmacology (8th ed.). Elsevier Churchill Livingstone.
- Goodman, L. S., & Gilman, A. (2011). Goodman & Gilman’s The Pharmacological Basis of Therapeutics (12th ed.). McGraw-Hill.
- Ganong, W. F. (2019). Ganong’s Review of Medical Physiology (26th ed.). McGraw-Hill Education.
- Kulkarni, S. K. (2015). Handbook of Experimental Pharmacology (3rd ed.). Vallabh Prakashan.
